%A 刘梦实，杨海燕，李红梅 %T Bevacizumab in the treatment of non-small-cell lung cancer with brain metastases %0 Journal Article %D 2017 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2017.11.015 %P 864-865 %V 44 %N 11 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10354.shtml} %8 2017-11-08 %X The occurrence of brain metastases in lung cancer affects the prognosis of patients. Following surgery, whole brain radiotherapy, stereotactic radiotherapy and chemotherapy, antiangiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases. As an antiangiogenic drug, bevacizumab has a better effect of controlling peritumoral edema. Studies have shown that bevacizumab combined with chemotherapy, radiotherapy to treat nonsmall cell lung cancer with brain metastasis has a good efficacy and safety.